W7 Diabetes Type 2 (AG) Flashcards

1
Q

What is the definition of Type 2 diabetes?

A

Type 2 diabetes is a chronic metabolic condition characterised by insulin resistance.
Insufficient pancreatic insulin production
also occurs progressively over time, resulting
in hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the ranges for persistent hyperglycaemia?

A

*HbA1c of 48 mmol/mol (6.5%) or more.
*Fasting plasma glucose level of 7.0 mmol/L or more.
*Random plasma glucose of 11.1 mmol/L or more in the presence of symptoms or signs
of diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical features of type 2 diabetes?

A
  • Polydipsia, polyuria, blurred vision, unexplained weight loss, recurrent infections, and tiredness.
  • Acanthosis nigricans (a skin condition causing dark pigmentation of skin folds, typically the axillae, groin, and neck), which suggests insulin resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the risk factors for type 2 diabetes?

A

*Obesity and inactivity
*Family history
*Ethnicity
*History of gestational diabetes
*Diet
*Drug treatments: statins, corticosteroids, and combined treatment with a thiazide
diuretic plus a β-blocker
*Polycystic ovary syndrome
*Metabolic syndrome: a combination of raised blood pressure, dyslipidaemia, fatty liver
disease, central obesity, and a tendency to develop thrombosis.
*Low birth weight for gestational age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does DESMOND stand for?

A

Diabetes Education and Self Management for Ongoing and Newly Diagnosed
➢ Individualised care
➢ Education

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the Treatment & HbA1c targets for T2DM? (2)
What is classed as poor control of diabetes?

A
  • A target HbA1c of 48 mmol/mol (6.5%) is
    recommended when managed by diet and
    lifestyle alone or when combined with a single
    anti-diabetic drug such as metformin
  • Adults prescribed a single drug associated
    with hypoglycaemia (such as sulphonylurea),
    or two or more anti-diabetic drugs, should aim for an HbA1c of 53 mmol/mol (7.0%)
  • Poor control of diabetes is defined as a
    HbA1c of 58 mmol/mol (7.5%) or higher - drug treatment should be intensified
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blood glucose monitoring:
Self-monitoring of blood-glucose concentration is appropriate for which patients with type 2 diabetes? (2)
Why? (2)

A
  • who are treated with insulin;
  • who are treated with oral hypoglycaemia
    drugs e.g. sulfonylureas
    -to monitor changes in blood-glucose
    resulting from changes in lifestyle or medication or during illness
    -to ensure safe blood glucose during
    activities including driving
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Do not routinely offer self-monitoring of capillary blood glucose levels for adults with
type 2 diabetes unless? (4)

A
  • the person is on insulin or
  • there is evidence of hypoglycaemic episodes or
  • the person is on oral medication that may increase their risk of hypoglycaemia while
    driving or operating machinery or
  • the person is pregnant or is planning to become pregnant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment guidelines

A
  1. Assess HbA1c, cardiovascular risk, kidney function
    * Symptomatic hyperglycaemia- Insulin or a sulfonylurea
    * Diet and lifestyle advice

Not at high CVD risk:
- Metformin
- Metformin MR (GI disturbance)

Chronic heart failure or established atherosclerotic CVD:
* Metformin
* Metformin MR (GI disturbance)
* As soon as metformin tolerability is confirmed- SGLT2 inhibitor (“flozin”)

High risk of CVD:
* Metformin
* Metformin (GI disturbance)
* As soon as metformin tolerability is confirmed- SGLT2 inhibitor (“flozin”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

First-line drug treatments?

A

DP-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diabetes mellitus
Diabetes & driving:

A
  • Drivers may be required to notify DVLA of their condition (if they’re taking insulin or have hypoglycaemic episodes). Drivers treated with insulin should always carry a glucose meter and strips when driving, must check no more than 2 hours before driving and every 2 hours while driving.
  • Blood-glucose should always be above 5
    mmol/L while driving
    . If it falls below 5 a fast-acting carbohydrate snack should be taken

If blood-glucose is less than 4 mmol/L or warning signs of hypoglycaemia develop- the driver should not drive:
* stop the vehicle in a safe place
* switch off engine, remove keys from the
ignition and move from the driver’s seat
* eat or drink a suitable source of sugar
* wait until 45 minutes after blood glucose has returned to normal, before continuing
journey,

Drivers must not drive if hypoglycemia awareness has been lost and the DVLA must be notified; driving may resume if a medical report confirms that awareness has been regained.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diabetes mellitus- Acute illness
What rules must patients adhere to?

A

During a period of illness that does not require admission, remind the person to adhere to the following ‘sick-day rules’ which should have been provided by their diabetes team. They should:

  • Not stop their insulin therapy.
  • Monitor their blood glucose levels more frequently.
  • Consider ketone monitoring (blood or urine).
  • Maintain their normal meal pattern (where possible) if appetite is reduced.
  • Aim to drink at least 3 L of fluid (5 pints) a day to prevent dehydration.
  • Seek urgent medical advice if they are violently sick, drowsy, or unable to keep fluids down.
  • When feeling better, continue to monitor their blood glucose carefully until it returns to normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diabetes mellitus- Acute illness
What are the SADMAN rules?

A

There are several drug classes that should be temporarily stopped in conditions that could lead to complications

S- SGLT2 Inhibitors (inc risk of euglycaemic DKA)
A- ACE inhibitors ( inc risk of AKI)
D- Diuretics ( inc risk of AKI)
M- Metformin (inc risk of lactic acidosis)
A- ARBs (inc risk of AKI)
N- NSAIDs (inc risk of AKI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Complications of T2DM?

A

o Microvascular complications — retinopathy, nephropathy, and neuropathy.
o Macrovascular complications — cardiovascular disease (CVD), cerebrovascular disease, and
peripheral arterial disease (PAD).
o Metabolic complications — dyslipidaemia and diabetic ketoacidosis (DKA, uncommon).
o Psychological complications — including anxiety and depression.
o Reduced quality of life.
o Reduced life expectancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is HHS?
Symptoms?
Treatment?

A

Hyperosmolar hyperglycaemic state (HHS)

Definition: very high blood glucose levels (often over 40mmol/l).

HHS symptoms can frequently include:
* urination,
* thirst
* nausea
* dry skin
* disorientation and, in later stages, drowsiness and a gradual loss of consciousness.

Treatment:
* Fluids to hydrate you.
* Electrolytes (such as potassium) to balance the minerals in your body.
* Insulin to regulate your blood sugar levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mr Tanvir Akua, a 35-year-old male patient, present at the pharmacy with a prescription for vildagliptin. He informs you that this is a new medication that his GP has added to his treatment for type 2 diabetes.

Which of the following would be appropriate advice to give Mr T when dispensing his prescription for vildagliptin?
A. Mr Akua should avoid exposure to sunlight whilst taking vildagliptin
B. Mr Akua should seek immediate medical attention if he experiences nausea, vomiting, abdominal pain, fatigue or dark urine
C. Mr Akua should take vildagliptin on an empty stomach, at least one hour before food
D. Mr Akua should monitor his blood pressure whilst taking vildagliptin
E. Mr Akua should temporarily stop taking vildagliptin if he has vomiting, diarrhoea or fever

A

=B
Vildagliptin Inhibits dipeptidylpeptidase-4 to increase insulin secretion and lower glucagon secretion.

BNF Caution: Liver toxicity

  • Monitor liver function before treatment and every 3 months for first year and periodically
    thereafter
  • Rare reports of liver dysfunction; discontinue if jaundice or other signs of liver dysfunction
    occur.
  • Discontinue if symptoms of acute pancreatitis occur, such as persistent severe abdominal pain.
17
Q

Dose of Tresiba
A. 22.4 units
B. 15 units
C. 30 units
D. 28 units
E. 24 units
F. 27.2 units
G. 25.6 units
H. 10 units

For patients described select the most suitable starting dose of Tresiba from the list
above. Each option may be used once, more than once or not at all.

Mr V is a 59-year-old man who has type 2 diabetes and stage 2 CKD. He is currently
taking pioglitazone and gliclazide in addition to Humulin I 15 units twice daily. However,
he is finding it difficult to administer his insulin twice daily and the endocrinologist
decides to start him on Tresiba.

A

= E 24 units

Switching a type 2 diabetic from twice daily basal insulin:
15 units twice daily =30 units humulin I
* 20% of 30 units is 6 units = 30-6= 24

NOTE: There is no difference in the pharmacokinetics of Tresiba between elderly and younger adult patients, between races or between healthy subjects and patients with renal or hepatic impairment